Mont-Saint-Guibert, Belgium – Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following conferences in January 2021:
H.C. Wainwright BioConnect Conference
Date: January 11 – 14, 2021
Time: On-demand, January 11 at 6:00 a.m. (EST) / 12:00 p.m. CET
Webcast: A live and archived webcast of the presentation will be available in the Events section of the Celyad Oncology website
Keystone eSymposia
Date: Monday, January 25, 2021
Time: 10:00 a.m. ET / 4:00 p.m. CET
A live and archived webcast of available presentations will be on the Events section of the Celyad Oncology website
